Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) EBITDA Margin (2025)

Historic EBITDA Margin for Coeptis Therapeutics Holdings (COEP) over the last 1 years, with Q3 2025 value amounting to 1043.22%.

  • Coeptis Therapeutics Holdings' EBITDA Margin changed N/A to 1043.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 2638.23%, marking a year-over-year change of. This contributed to the annual value of 18727.91% for FY2021, which is N/A changed from last year.
  • Per Coeptis Therapeutics Holdings' latest filing, its EBITDA Margin stood at 1043.22% for Q3 2025.
  • In the past 5 years, Coeptis Therapeutics Holdings' EBITDA Margin registered a high of 1043.22% during Q3 2025, and its lowest value of 6452.56% during Q1 2025.